UBS Group Cuts Owens & Minor (NYSE:OMI) Price Target to $25.00

Owens & Minor (NYSE:OMI) had its price target decreased by UBS Group from $28.00 to $25.00 in a report issued on Tuesday,Benzinga reports. UBS Group currently has a buy rating on the stock.

OMI has been the topic of a number of other reports. Barclays decreased their price target on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Citigroup decreased their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. lowered their price target on Owens & Minor from $22.00 to $18.00 and set an “underweight” rating for the company in a research report on Wednesday, August 21st. Robert W. Baird cut their target price on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research note on Tuesday. Finally, StockNews.com cut Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Stock Performance

Shares of Owens & Minor stock traded down $0.23 during trading on Tuesday, hitting $12.53. 25,801 shares of the company’s stock were exchanged, compared to its average volume of 834,575. The stock has a market capitalization of $966.01 million, a price-to-earnings ratio of -19.63, a PEG ratio of 0.39 and a beta of 0.41. The business has a 50-day simple moving average of $14.35 and a 200-day simple moving average of $16.06. Owens & Minor has a 52-week low of $11.42 and a 52-week high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.51 and a current ratio of 1.09.

Owens & Minor (NYSE:OMI) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue was up 5.0% on a year-over-year basis. On average, research analysts forecast that Owens & Minor will post 1.55 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in OMI. Vanguard Group Inc. increased its position in Owens & Minor by 1.9% during the first quarter. Vanguard Group Inc. now owns 8,749,866 shares of the company’s stock worth $242,459,000 after buying an additional 162,182 shares in the last quarter. Deerfield Management Company L.P. Series C lifted its stake in shares of Owens & Minor by 30.6% during the second quarter. Deerfield Management Company L.P. Series C now owns 6,371,440 shares of the company’s stock valued at $86,014,000 after buying an additional 1,493,852 shares during the period. Dimensional Fund Advisors LP boosted its position in Owens & Minor by 1.7% during the second quarter. Dimensional Fund Advisors LP now owns 4,534,204 shares of the company’s stock worth $61,213,000 after acquiring an additional 76,599 shares during the last quarter. Renaissance Technologies LLC grew its stake in Owens & Minor by 16.5% in the 2nd quarter. Renaissance Technologies LLC now owns 1,246,600 shares of the company’s stock worth $16,829,000 after acquiring an additional 176,250 shares during the period. Finally, Dana Investment Advisors Inc. raised its holdings in Owens & Minor by 35.8% in the 2nd quarter. Dana Investment Advisors Inc. now owns 609,040 shares of the company’s stock valued at $8,222,000 after acquiring an additional 160,682 shares during the last quarter. 98.04% of the stock is owned by hedge funds and other institutional investors.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.